289 related articles for article (PubMed ID: 32517266)
1. Propagation, Inactivation, and Safety Testing of SARS-CoV-2.
Jureka AS; Silvas JA; Basler CF
Viruses; 2020 Jun; 12(6):. PubMed ID: 32517266
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Inactivation of SARS-CoV-2 by Specimen Transport Media, Nucleic Acid Extraction Reagents, Detergents, and Fixatives.
Welch SR; Davies KA; Buczkowski H; Hettiarachchi N; Green N; Arnold U; Jones M; Hannah MJ; Evans R; Burton C; Burton JE; Guiver M; Cane PA; Woodford N; Bruce CB; Roberts ADG; Killip MJ
J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32839250
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples.
Pastorino B; Touret F; Gilles M; Luciani L; de Lamballerie X; Charrel RN
Viruses; 2020 Jun; 12(6):. PubMed ID: 32521706
[TBL] [Abstract][Full Text] [Related]
4. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
[TBL] [Abstract][Full Text] [Related]
5. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
6. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
[TBL] [Abstract][Full Text] [Related]
7. Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
Clementi N; Ferrarese R; Criscuolo E; Diotti RA; Castelli M; Scagnolari C; Burioni R; Antonelli G; Clementi M; Mancini N
J Infect Dis; 2020 Aug; 222(5):722-725. PubMed ID: 32559285
[TBL] [Abstract][Full Text] [Related]
8. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.
Matsuyama S; Nao N; Shirato K; Kawase M; Saito S; Takayama I; Nagata N; Sekizuka T; Katoh H; Kato F; Sakata M; Tahara M; Kutsuna S; Ohmagari N; Kuroda M; Suzuki T; Kageyama T; Takeda M
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7001-7003. PubMed ID: 32165541
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting stability and infectivity of SARS-CoV-2.
Chan KH; Sridhar S; Zhang RR; Chu H; Fung AY; Chan G; Chan JF; To KK; Hung IF; Cheng VC; Yuen KY
J Hosp Infect; 2020 Oct; 106(2):226-231. PubMed ID: 32652214
[TBL] [Abstract][Full Text] [Related]
10. Methods of Inactivation of SARS-CoV-2 for Downstream Biological Assays.
Patterson EI; Prince T; Anderson ER; Casas-Sanchez A; Smith SL; Cansado-Utrilla C; Solomon T; Griffiths MJ; Acosta-Serrano Á; Turtle L; Hughes GL
J Infect Dis; 2020 Oct; 222(9):1462-1467. PubMed ID: 32798217
[TBL] [Abstract][Full Text] [Related]
11. Propagation and Quantification of SARS-CoV-2.
Jureka AS; Basler CF
Methods Mol Biol; 2022; 2452():111-129. PubMed ID: 35554904
[TBL] [Abstract][Full Text] [Related]
12. Rapid inactivation of SARS-CoV-2 with deep-UV LED irradiation.
Inagaki H; Saito A; Sugiyama H; Okabayashi T; Fujimoto S
Emerg Microbes Infect; 2020 Dec; 9(1):1744-1747. PubMed ID: 32673522
[TBL] [Abstract][Full Text] [Related]
13. Effects of Different Temperature and Time Durations of Virus Inactivation on Results of Real-time Fluorescence PCR Testing of COVID-19 Viruses.
Wu ZG; Zheng HY; Gu J; Li F; Lv RL; Deng YY; Xu WZ; Tong YQ
Curr Med Sci; 2020 Aug; 40(4):614-617. PubMed ID: 32767258
[TBL] [Abstract][Full Text] [Related]
14. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated
Chan JF; Yip CC; To KK; Tang TH; Wong SC; Leung KH; Fung AY; Ng AC; Zou Z; Tsoi HW; Choi GK; Tam AR; Cheng VC; Chan KH; Tsang OT; Yuen KY
J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32132196
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 and the safety margins of cell-based biological medicinal products.
Modrof J; Kerschbaum A; Farcet MR; Niemeyer D; Corman VM; Kreil TR
Biologicals; 2020 Nov; 68():122-124. PubMed ID: 32891497
[TBL] [Abstract][Full Text] [Related]
16. Two Detailed Plaque Assay Protocols for the Quantification of Infectious SARS-CoV-2.
Mendoza EJ; Manguiat K; Wood H; Drebot M
Curr Protoc Microbiol; 2020 Jun; 57(1):ecpmc105. PubMed ID: 32475066
[TBL] [Abstract][Full Text] [Related]
17. Growth, detection, quantification, and inactivation of SARS-CoV-2.
Case JB; Bailey AL; Kim AS; Chen RE; Diamond MS
Virology; 2020 Sep; 548():39-48. PubMed ID: 32838945
[TBL] [Abstract][Full Text] [Related]
18. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
19. Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.
Yang D; Chu H; Hou Y; Chai Y; Shuai H; Lee AC; Zhang X; Wang Y; Hu B; Huang X; Yuen TT; Cai JP; Zhou J; Yuan S; Zhang AJ; Chan JF; Yuen KY
J Infect Dis; 2020 Aug; 222(5):734-745. PubMed ID: 32563187
[TBL] [Abstract][Full Text] [Related]
20. The COVID-19 pandemic.
Ciotti M; Ciccozzi M; Terrinoni A; Jiang WC; Wang CB; Bernardini S
Crit Rev Clin Lab Sci; 2020 Sep; 57(6):365-388. PubMed ID: 32645276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
